Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

Executive Summary Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De

Integrating Artificial Intelligence (AI) into the health system has the potential to enhance efficiency, accessibility, and overall quality of medical services worldwide. In response to global advancements, Thailand proactively developed the National AI Strategy and Action Plan 2022–2027, which emphasises AI adoption in health as a national prior

The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th

This study aims to assess both the cost and the appropriate medical indications of using Positron Emission Tomography-Computed Tomography (PET-CT) under the Thai setting. It also estimates the potential need and supply to meet the need of PET-CT within the next five years. A systematic review and meta-analysis of literature published in the PubMed

Ministry of Public Health, the Royal Thai Government, has been entrusted by the World Health Organization (WHO) to co-host the First Global Forum on Medical Devices, scheduled to take place September 9th-11th, 2010, at the Hotel Plaza Athenee, Bangkok. The event attracted over 300 stakeholders, such as policy makers, scholars and health professiona

The Health Intervention and Technology Assessment Program (HITAP) was established in 2007 as a non-profit organization. Its main responsibility is to assess health interventions and technology assessment with the coverage of pharmaceuticals, medical devices, interventions, individual and community health promotions and disease prevention, as well a

An aim of this study is to describe quantitatively and qualitatively progression and findings from the HTA topic selection process recently developed by HITAP. The process involves potential users of HTA information; namely (1) third party payers (public health insurers), (2) national health care program managers (Ministry of Public Health’s Depa